⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLBT News
Cellebrite DI Ltd. Class A Ordinary Shares
Cellebrite completa la adquisición de SCG Canada, Inc., líder en análisis forense de drones USA - español USA - Français BRAZIL - Portuguese APAC - Thai USA - Deutsch Japan - Japanese USA - English Korea - 한국어 APAC - English MEXICO - Spanish
prnewswire.com
CLBT
Cellebrite Completes Acquisition of Drone Forensics Leader SCG Canada, Inc. USA - English USA - Français BRAZIL - Portuguese APAC - Thai USA - español USA - Deutsch Japan - Japanese Korea - 한국어 APAC - English MEXICO - Spanish
prnewswire.com
CLBT
Cellebrite finalise l'acquisition de SCG Canada, Inc., le leader des solutions médico-légales pour les drones USA - Français APAC - English BRAZIL - Portuguese Korea - 한국어 Japan - Japanese MEXICO - Spanish
prnewswire.com
CLBT
Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results USA - English APAC - English Israel - English
prnewswire.com
CLBT
TransPerfect Legal's Michael Kriegal Named Excellence in eDiscovery Award Finalist
prnewswire.com
CLBT
Cellebrite Branchentrend-Bericht 2026: Smartphones mit 97 % die wichtigste Quelle für digitale Beweismittel in Ermittlungen USA - Deutsch MEXICO - Spanish APAC - English Israel - English USA - español Korea - 한국어 Japan - Japanese APAC - Thai BRAZIL -
prnewswire.com
CLBT
Le rapport Cellebrite sur les tendances de l'industrie en 2026 révèle que dans 97 % des cas les smartphones sont la principale source de preuves numériques dans les enquêtes USA - Français Japan - Japanese APAC - Thai BRAZIL - Portuguese Korea - 한국어
prnewswire.com
CLBT
Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97% USA - English USA - español Israel - English APAC - English Korea - 한국어 Japan - Japanese APAC - Thai MEXICO - Spanish BRAZIL -
prnewswire.com
CLBT
El Informe de Tendencias de la Industria 2026 de Cellebrite revela que los smartphones son la principal fuente de evidencia digital en las investigaciones con un 97% de participación USA - español Israel - English APAC - English BRAZIL - Portuguese Korea
prnewswire.com
CLBT
Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers
globenewswire.com
CLBT